Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Immorna Raises $100 Million for Clinical Trials of Novel RNA Candidates

publication date: Mar 1, 2023

Immorna, a Hangzhou company developing novel RNA therapeutic and vaccine candidates, raised $100 million in a Series A+/A++ funding to support clinical development of its portfolio. Founded in 2019, the company has built multiple RNA platforms for conventional, self-replicating and circular RNA technologies. With its advanced screening tools, Immorna has developed several RNA delivery vehicles. Immorna has a total of 11 RNA candidates that target indications in cancer immunotherapy, infectious diseases, rare genetic diseases and cosmology. The company has approval to start three clinical trials for two assets in the US. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here